We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
+10.68%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$400B
AUM Growth
+$26.1B
Cap. Flow
-$7.15B
Cap. Flow %
-1.79%
Top 10 Hldgs %
12.04%
Holding
2,531
New
100
Increased
822
Reduced
1,027
Closed
76

Sector Composition

Rank Sector Weight
1 Healthcare 14.93%
2 Consumer Discretionary 13.87%
3 Financials 13.55%
4 Industrials 11.68%
5 Technology 10.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NGD
1226
DELISTED
New Gold Inc
NGD
$11.6M ﹤0.01%
1,940,158
-579,600
-23% -$3.95M
WLL
1227
DELISTED
Whiting Petroleum Corporation
WLL
$11.6M ﹤0.01%
644
-3
-0.5% -$46.5K
CATM
1228
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
$11.5M ﹤0.01%
309,794
+5,394
+2% +$182K
DPZ icon
1229
Domino's
DPZ
$11.6B
$11.4M ﹤0.01%
168,164
+153,800
+1,071% +$9.72M
CYNO
1230
DELISTED
Cynosure, Inc. Class A
CYNO
$11.4M ﹤0.01%
499,357
-38,800
-7% -$964K
RTEC
1231
DELISTED
Rudolph Technologies Inc
RTEC
$11.4M ﹤0.01%
998,000
+263,300
+36% +$3.02M
KMG
1232
DELISTED
KMG Chemicals Inc
KMG
$11.3M ﹤0.01%
513,090
-11,230
-2% -$257K
SPTN
1233
DELISTED
SpartanNash
SPTN
$11.2M ﹤0.01%
507,989
+65,789
+15% +$1.38M
TVTY
1234
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$11.2M ﹤0.01%
604,100
-3,000
-0.5% -$54.2K
HRB icon
1235
H&R Block
HRB
$6.76B
$11.1M ﹤0.01%
417,858
-4,400
-1% -$128K
ACOR
1236
DELISTED
Acorda Therapeutics
ACOR
$11.1M ﹤0.01%
2,704
+7
+0.3% +$30.2K
BCIC
1237
BCP Investment Corp
BCIC
$95.6M
$11.1M ﹤0.01%
123,362
+4,297
+4% +$409K
AENZ
1238
DELISTED
Aenza S.A.A.
AENZ
$11.1M ﹤0.01%
+184,835
New +$11.4M
SFLY
1239
DELISTED
Shutterfly, Inc.
SFLY
$11.1M ﹤0.01%
197,900
+11,100
+6% +$617K
WCRX
1240
DELISTED
WARNER CHILCOTT PLC ORD SHS CL A (IRL)
WCRX
$11M ﹤0.01%
483,200
-2,700
-0.6% -$57.1K
GTLS
1241
DELISTED
Chart Industries
GTLS
$11M ﹤0.01%
89,500
+400
+0.4% +$45K
LKQ icon
1242
LKQ Corp
LKQ
$6.25B
$10.9M ﹤0.01%
343,090
-5,100
-1% -$147K
LCAV
1243
DELISTED
LCA-VISION INC
LCAV
$10.9M ﹤0.01%
3,034,265
-500
-0% -$1.77K
CYTK icon
1244
Cytokinetics
CYTK
$10.2B
$10.9M ﹤0.01%
1,431,573
-42,285
-3% -$454K
WD icon
1245
Walker & Dunlop
WD
$1.45B
$10.9M ﹤0.01%
682,963
-39,200
-5% -$646K
GHL
1246
DELISTED
Greenhill & Co., Inc.
GHL
$10.8M ﹤0.01%
217,413
-23,500
-10% -$1.16M
GNW icon
1247
Genworth Financial
GNW
$3.77B
$10.8M ﹤0.01%
841,300
+73,010
+10% +$915K
CMA
1248
DELISTED
Comerica
CMA
$10.7M ﹤0.01%
272,931
-6,900
-2% -$287K
SUSS
1249
DELISTED
SUSSER HOLDINGS CORPORATION COMMON STOCK
SUSS
$10.7M ﹤0.01%
201,200
-7,800
-4% -$390K
DNR
1250
DELISTED
Denbury Resources, Inc.
DNR
$10.6M ﹤0.01%
573,087
-10,300
-2% -$181K

Similar funds

T. Rowe Price Associates's Q3 2013 Portfolio in Review

As of Q3 2013, T. Rowe Price Associates held 2,531 positions worth $400B, up 7% from $374B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

T. Rowe Price Associates's Q3 2013 filing shows 100 new, 822 increased, 1,027 reduced and 76 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 36,580,054 shares worth $1.23B. The largest sale was NEWS CORPORATION CL-A, an estimated $909M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 36,580,054 shares worth $1.23B.
  • T. Rowe Price Associates added most to Apple in Q3 2013, an estimated $742M increase.
  • T. Rowe Price Associates's biggest Q3 2013 reduction was Union Pacific, cutting an estimated $741M.
  • T. Rowe Price Associates fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $909M.
  • T. Rowe Price Associates's ten largest holdings make up 12% of its $400B portfolio in Q3 2013.
  • T. Rowe Price Associates opened 100 new positions and closed 76 in Q3 2013.
  • T. Rowe Price Associates's portfolio value rose 7% quarter-over-quarter to $400B.

Based on T. Rowe Price Associates's 13F filing for Q3 2013, filed 14 Nov 2013.